Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38819 for Org 36286 (Corifollitropin Alfa)
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Corifollitropin alfa (Primary) ; Recombinant follicle-stimulating hormone
- Indications Infertility
- Focus Adverse reactions; Registrational
- Sponsors Merck Sharp & Dohme; Organon
- 18 Feb 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
- 18 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History